New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
OrganiGram Holdings Inc.
OGI
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

187M

Drug Manufacturers - Specialty & Generic

Next Earning date - 17 Dec 2024

187M

Drug Manufacturers - Specialty & Generic

Next Earning date - 17 Dec 2024

1.72USD
Shape0.06 ( 3.61%)
favorite-chart

Relative Strenght

30
favorite-chart

Volume Buzz

-66%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

41%

Quote Panel

Shape
Updated October 13, 2024
1W 0.00 % 1M -8.99 % 3M 0.58 % 1Y 45.76 %

Key Metrics

Shape
  • Market Cap

    186.75M


  • Shares Outstanding

    108.57M


  • Share in Float

    75.85M


  • Dividende

    0


  • Earning Date

    17 Dec 2024


  • Price Target

    1.72


  • Average Volume

    567434


  • Beta

    1.128


  • Range

    0.97-2.91


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.organigram.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.59x

P/S Ratio

0.83x

P/B Ratio

0.0

Debt/Equity

-45.3%

Net Margin

$-1.8

EPS

How OGI compares to sector?

P/E Ratio

Relative Strength

Shape

OGI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$184M

Shape347%

2025-Revenue

$0.15

Shape456%

2025-EPS

$58M

Shape-266%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Alliance Global Partners

upgrade

Previous: Not converted

2024-04-15

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.08
vs -0.28

Q4.22

arrow
arrow

N/A

-0.04
vs -0.12

Q1.23

arrow
arrow

N/A

-0.08
vs -0.08

Q2.23

arrow
arrow

N/A

-0.15
vs -0.12

Q3.23

arrow
arrow

N/A

-0.08
vs -0.08

Q4.23

arrow
arrow

N/A

-0.14
vs -0.04

Q1.24

arrow
arrow

N/A

-0.12
vs -0.08

Q2.24

arrow
arrow

+113%

0.02
vs -0.15

Q3.24

arrow
arrow

N/A

-0.02
vs -0.08

Q4.24

arrow
arrow

N/A

-0.01
vs -0.14

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+83%

45.5M  vs 24.9M

Q4.22

arrow
arrow

+43%

43.3M  vs 30.4M

Q1.23

arrow
arrow

+24%

39.5M  vs 31.8M

Q2.23

arrow
arrow

-14%

32.8M  vs 38.1M

Q3.23

arrow
arrow

+1%

46M  vs 45.5M

Q4.23

arrow
arrow

-16%

36.5M  vs 43.3M

Q1.24

arrow
arrow

-5%

37.6M  vs 39.5M

Q2.24

arrow
arrow

+25%

41.1M  vs 32.8M

Q3.24

arrow
arrow

+4%

47.9M  vs 46M

Q4.24

arrow
arrow

+29%

47M  vs 36.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-1%

-0.01
vs -0.01

Q4.22

arrow
arrow

+1%

0.01
vs -0.01

Q1.23

arrow
arrow

-1%

-0.01
vs 0.01

Q2.23

arrow
arrow

-71%

-0.71
vs -0.01

Q3.23

arrow
arrow

-12%

-0.12
vs -0.71

Q4.23

arrow
arrow

-6%

-0.06
vs -0.12

Q1.24

arrow
arrow

-10%

-0.10
vs -0.06

Q2.24

arrow
arrow

+1%

0.01
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

134

134
vs 127

6%

Q1.22

arrow
arrow

126

126
vs 134

-6%

Q2.22

arrow
arrow

125

125
vs 126

-1%

Q3.22

arrow
arrow

107

107
vs 125

-14%

Q4.22

arrow
arrow

124

124
vs 107

16%

Q1.23

arrow
arrow

114

114
vs 124

-8%

Q2.23

arrow
arrow

78

78
vs 114

-32%

Q1.24

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News

OGI

seekingalpha.com

7 hours ago